Phase I Trial of an ICAM-1-Targeted Immunotherapeutic-Coxsackievirus A21 (CVA21) as an Oncolytic Agent Against Non Muscle-Invasive Bladder Cancer
| Image |  |
|---|---|
| Description | scientific article published on 04 July 2019 |
| Author/s |
author: Bernard A Fox Hugh Mostafid Carmen Ballesteros-Merino Hardev Pandha Nicola Annels |
| Publication date | July 4, 2019 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |